Physician profile
David L Parrish
NPI 1841288453
$1,764.42
in general payments reported to CMS, 2019-2025
20 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $142 · 2021: $24.83 · 2022: $46.96 · 2023: $346 · 2024: $201 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $312.99 | 2021-2025 | Cardiomems, Gallant, Aveir |
| E.R. Squibb & Sons, L.L.C. | $248.41 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $178.15 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.28 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $133.54 | 2019-2020 | |
| Boston Scientific Corporation | $119.50 | 2025 | Avvigo Guidance System |
| Janssen Pharmaceuticals, INC | $110.69 | 2019-2020 | |
| Amarin Pharma, INC. | $68.34 | 2019 | |
| Cook Medical LLC | $61.17 | 2025 | Zenith Spiral-Z |
| Pfizer INC. | $59.81 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $58.55 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $57.52 | 2019 | |
| Amgen INC. | $45.48 | 2019 | |
| Novo Nordisk INC | $35.39 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $33.76 | 2025 | Inspire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.07 | 2024 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals International, Plc | $17.68 | 2024 | Arcalyst |
| Heartflow, INC. | $16.23 | 2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.86 | 2025 | Lifevest |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.